Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr October ZOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,514
Closed -$266K 166
2024
Q4
$266K Buy
+10,514
New +$265K 0.08% 134

Other funds holding ZOCT

Prostatis Group's ZOCT Position: Q1 2025 in Review

Prostatis Group sold out of Innovator Equity Defined Protection ETF - 1 Yr October (ZOCT) in Q1 2025, closing a stake of 10,514 shares — an estimated $266K sold.

Prostatis Group first reported a position in ZOCT in Q4 2024 and held it in 1 quarter. The position peaked at $266K in Q4 2024. 50 funds tracked by Wall St. Rank hold ZOCT as of Q1 2025.

  • Prostatis Group reported no remaining Innovator Equity Defined Protection ETF - 1 Yr October position as of Q1 2025 after selling out during the quarter.
  • Prostatis Group sold 10,514 Innovator Equity Defined Protection ETF - 1 Yr October shares in Q1 2025, an estimated $266K.
  • Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr October in Q4 2024 and held it in 1 quarter.
  • Prostatis Group's Innovator Equity Defined Protection ETF - 1 Yr October position peaked at $266K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr October as of Q1 2025.

Based on Prostatis Group's 13F filing for Q1 2025, filed 16 May 2025.